Study of precise selective regional lymphadenectomy in neoadjuvant radiochemotherapy combined with liver transplantation for viral hepatitis B-associated intrahepatic cholangiocarcinoma

Strategy of liver transplantation for intrahepatic cholangiocarcinoma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIC-17010664

Enrollment

Unknown

Registered

2017-02-17

Start date

2017-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrahepatic cholangiocarcinoma

Interventions

lymphadenectomy group:selective regional lymphadenectomy with neoadjuvant radiochemotherapy

Control:selective regional lymphadenectomy without neoadjuvant radiochemotherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. typical radiological manefestation of intrahepatic cholangiocarcinoma; 2. serum CA19-9 more than 100U/ml; 3. HBsAg(+); 4. biopsy if necessary; 5. unresectable ICC.

Exclusion criteria

Exclusion criteria: 1. hilar cholangiocarcinoma; 2. major vascular invasion; 3. extrahepatic lymphatic metastasis; 4. extrahepatic metastasis; 5. severe infection; 6. chronic renal dysfuction; 7. other malignant tumors within five years.

Design outcomes

Primary

Measure	Time frame
overall survival rate;relapse free survival rate;	—

Secondary

Measure	Time frame
quality of life;	—

Countries

China

Contacts

Public ContactGu Jinyang

Affiliated Renji Hospital, School of Medicine, Shanghai Jiaotong University

gjynyd@126.com+86 15000596988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026